Шляхи оптимізації лікування хворих із незадовільним прогнозом кінцевого зросту
DOI:
https://doi.org/10.24026/1818-1384.2(39).2012.82479Ключові слова:
growth retardation, children, recombinant growth hormone, luteinizing hormone analog-releasing hormone, treatmentАнотація
The article describes and analyzes the results of numerous clinical studies on the correction of short stature in children with various endocrine disorders, such as precocious puberty, after the removal of produced androgen-adrenal tumors, congenital dysfunction of the adrenal cortex, a spondyloepiphyseal dysplasia, Shereshevsky-Turner syndrome, growth hormone deficiency, idiopathic growth retardation, biologically inactive growth hormone. Presented own data on treatment outcomes in the application of recombinant growth hormone preparations and analogues luteinizing hormone -releasing hormone in children with poor prognosis of growth.
Посилання
Oostdijk W., Drop S.J.S., Odink R.J.H. et al. Long-term results with a slow-release gonadotrophin-release hormone agonist in central precocious puberty // Acta Paediatr. [Suppl] – 2001. – Vol. 372. – P. 39-45. https://doi.org/10.1111/j.1651-2227.1991.tb17967.x
J. Yanovski, S.R. Rose, G. Municchi [et al.] Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature // NEJM. – 2002. – Vol. 348. – P. 908-917. https://doi.org/10.1056/nejmoa013555
J.G. Buchlis, L. Irizarry, B.C. Crotzer [et al.] Comparison of final heights of growth hormone-treated vs. untreated children with idiopathic growth failure // J. Clin. Endocrinol. Metabol. – 1998. – Vol. 83. – P. 1075-1079. https://doi.org/10.1210/jc.83.4.1075
M. Toumba, I. Bacopoulou, S.C. Savva, N. Skordis. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height // Indian Pediatr. – 2007. – Vol. 44, №7. – P. 497-502.
Muthusamy K., Elamin M.B., Smushkin G. Adult Height in Patients with Congenital Adrenal Hyperplasia: A Systematic Review and Metaanalysis // The Journal of Clinical Endocrinology & Metabolism. – 2010. – Vol. 95. – №9. – P. 4161-4172. https://doi.org/10.1210/jc.2009-2616
Большова О. В., Самсон О. Я., Музь В. А. Особливості перебігу пубертатного періоду у хворих з соматотропною недостатністю. Методи медикаментозної корекції статевого дозрівання // Педіатрія, акушерство і гінекологія. – 2005. – №2.- С. 41-43.
M. Tauber, B. Berro, V. Delagnes [et al.] Can some growth hormone (GH)-deficient children benefit from combined therapy with gonadotropin-releasing hormone analogs and GH? Results of a retrospective study // J. Clin. Endocrinol. Metab. – Vol. 88, 13. – P. 1179-1183. https://doi.org/10.1210/jc.2002-020974
G. Saggese, G. Cesaretti, S. Barsanti, A. Rossi. Combination treatment with growth hormone and gonadotropin-releasing hormone analogs in short normal girls // J. Pediatr. – 1995. – Vol. 126. – P. 468-473. https://doi.org/10.1016/s0022-3476(95)70473-6
J.C. Carel, M. Roger, S. Ispas [et al.] Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment / / J. Clin. Endocrinol. Metabol. – 2005. – Vol. 84, №6. – P. 1973-1978. https://doi.org/10.1210/jcem.84.6.5647
E.C. Walvoord, O.H. Pescovitz. Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty: theoretic and practical considerations // Pediatrics. – 1999. – Vol. 104. – P. 1010-1014.
A. Morishima, M.M. Grumbach, E.R. Simpson [et al.] Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens // J. Clin. Endocrinol. Metabolism. - 1995. – Vol. 80. – P. 3689-3698. https://doi.org/10.1210/jcem.80.12.8530621
Horton W.A., Hecht J.T. Growth hormone therapy in achondroplasia // Am. J. Med. Genet. – 1992. – Vol. 42. – P. 667-670. https://doi.org/10.1002/ajmg.1320420508
Nguyen A.T., Brown J.J., Warne G.L. Growth in congenital adrenal hyperplasia // Indian J. Pediatr. – 2006. – Vol. 73, №1. – P. 89-93. https://doi.org/10.1007/bf02758268
K. Lin-Su, M.G. Vogiatzi, I. Marshall [et al.] Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia // J. Clin. Endocrinol. Metabolism. – 2005. – Vol. 90, №6. – P. 3318-3325. https://doi.org/10.1210/jc.2004-2128
Allen D.B., Julius J.R., Breen T.J., Attie K.M., Allen D.B. Treatment of glucocorticoid-induced growth suppression with growth hormone. National Cooperative Growth Study // J. Clin. Endocrinol. Metab. – 1998. – Vol. 83. – P. 2824-2829. https://doi.org/10.1210/jcem.83.8.5036
New M. Factors determining final height in congenital adrenal hyperplasia // J. Pediatr. Endocrinol. Metab. – 2001. – Vol. 14, Suppl. 2 – P. 933-937. https://doi.org/10.1515/jpem-2001-s204
Aycan Z., Ocal G., Berberoglu M., Cetinkaya E. [et al.] Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential // J. Pediatr. Endocrinol. Metab. – 2006. – Vol. 19(3). – P. 245-251. https://doi.org/10.1515/jpem.2006.19.3.245
Khadilkar V.V., Khadilkar A.V., Maskati G.B. Impact of availability of oral hydrocortisone on growth of children with CAH // Indian J. Pediatr. – 2005. – Vol. 72(4). – P. 301-303. https://doi.org/10.1007/bf02724009
J.-C. Carel, E.A. Eugster, A. Rogol [et al.] Consensus statement on the use of gonadotropine-releasing hormone analogs in children // Pediatrics. – 2009. – Vol. 123. – P. 752-762. https://doi.org/10.1542/peds.2008-1783
Dacou-Voutetakis C., Karidis N. Congenital adrenal hyperplasia complicated by central precocious puberty: treatment with LHRH-agonist analogue // Ann. NY Acad. Sci . – 1993. – Vol. 687. – P. 250-254. https://doi.org/10.1111/j.1749-6632.1993.tb43873.x
##submission.downloads##
Опубліковано
Як цитувати
Номер
Розділ
Ліцензія
Ця робота ліцензується відповідно до Creative Commons Attribution-NonCommercial 4.0 International License.
